No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
The Quality Adjusted Life Year (QALY) market is a key component of pharmacoeconomics, which is the study of the cost-effectiveness of pharmaceutical products. QALYs are a measure of the quality and quantity of life gained from a medical intervention, such as a drug or medical device. QALYs are used to compare the cost-effectiveness of different treatments and to inform healthcare decisions. QALYs are calculated by multiplying the number of years of life gained by the quality of life during those years. Quality of life is measured using a scale from 0 to 1, with 0 representing death and 1 representing perfect health.
Some companies in the QALY market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more
